Drugmakers push back on vaccine patent waiver

Video Credit: Reuters - Politics
Published on May 7, 2021 - Duration: 01:50s

Drugmakers push back on vaccine patent waiver

Drugmakers on Thursday said U.S. President Joe Biden's support for waiving patents of COVID-19 vaccines could disrupt a fragile supply chain and that rich countries should instead share more generously with the developing world.

This report produced by Jillian Kitchener.


Drugmakers push back on vaccine patent waiver

Drugmakers are pushing back against U.S. President Joe Biden’s show of support for waiving patents of COVID-19 vaccines.

Research-based pharmaceutical companies say such a move could disrupt a fragile supply chain… and that rich countries should instead share more with the developing world.

The International Federation of Pharmaceutical Manufacturers and Associations on Thursday said waiving intellectual property rights for COVID vaccines would invite new manufacturers that lack essential know-how to crowd out established contractors.

It would also set a bad precedent, says European patent attorney Micaela Modiano: "...It’s because of the patents that companies keep investing money into, looking for new treatments, better treatments and better vaccines, better drugs.

And and you would not have this kind of investment if if there wasn't a proper reward for these companies.

So the patent system was involved in for this system.

And I think it's, if I may say so, a bit silly to try to reinvent it now.” Shares of COVID-19 vaccine makers were initially rattled late on Wednesday after Biden said he backed a WTO-proposed waiver… and shares fell on Thursday.

But the WTO and the WHO applauded Biden's show of support... as they aim to help developing countries produce vaccines using the IP of pharmaceutical companies.

On Thursday, U.S. Secretary of State Antony Blinken said vaccinating the globe against COVID-19 needs to be sped up to beat mutations of the virus... and described a patent waiver as "one possible means” of increasing access to vaccines.

The next stop is for the World Trade Organization to hammer out a deal - but with lengthy negotiations, the process that could take months.

You are here


💡 newsR Knowledge: Other News Mentions


World Trade Organization

Intergovernmental trade organization
Prime Minister Narendra Modi on Saturday sought G7's support for the proposal moved at the WTO by India and South Africa for a TRIPS waiver on Covid-related..
Credit: IndiaTimes - Published 1 week ago

UN Secretary General Antonio Guterres has extended support to India and South Africa's initiative at the WTO to waive intellectual property protection for..
Credit: IndiaTimes - Published 1 week ago




Related videos from verified sources

Drugmakers say Biden misguided over vaccine patent waiver 01:43
Video credit: FRANCE 24 English - Published on May 6, 2021 

EU willing to discuss Covid-19 vaccine patent waiver, von der Leyen says 00:26
Video credit: FRANCE 24 English - Published on May 6, 2021 

Biden to back WTO COVID vaccine patent waiver 01:57
Video credit: Reuters - Politics - Published on May 5, 2021 

You might like